The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate cancer
放射性药物镭-223对患者具有免疫调节作用,并能促进骨转移性前列腺癌小鼠模型中抗程序性死亡受体-1疗法的疗效。
期刊:Radiotherapy and Oncology
影响因子:5.3
doi:10.1016/j.radonc.2024.110091
Saylor, Philip J; Kozin, Sergey V; Matsui, Aya; Goldberg, Saveli I; Aoki, Shuichi; Shigeta, Kohei; Mamessier, Emilie; Smith, Matthew R; Michaelson, M Dror; Lee, Richard J; Duda, Dan G